CIK: 1724311 - Address: C/O Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/12/24 16:44
11/7/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.d-46529.910-16-2702D
8/22/24 16:14
8/20/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.m-20023.990-8-1702D
8/15/24 16:10
8/13/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-5222.890-20710D
2/15/24 21:14
2/13/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.m-40217.620-23-3711D
1/9/24 19:34
1/5/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-19419.430-10-1684I
8/25/23 17:36
8/23/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-5823.170-30640I
8/23/23 16:33
8/21/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-5622.590-20643I
8/16/23 18:19
8/14/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-6623.670-30645I
8/14/23 17:11
8/10/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-6924.180-30648I
7/19/23 17:10
7/17/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.dm-58729.800-20-3651I
5/17/23 16:56
5/15/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.d-28628.600-10-1659I
4/14/23 18:27
4/12/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.dm-25025.040-10-1659I
2/15/23 19:01
2/13/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.d-10530.090-3-1659I
2/10/23 18:11
2/8/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-4730.890-20638I
1/19/23 17:09
1/17/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.d-29529.530-10-2640I
1/9/23 21:41
1/5/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-7528.440-30640I
1/9/23 16:05
1/4/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.a-8428.700-3-1492I
1/5/23 21:07
1/4/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS.d-8428.700-30642D
8/23/22 16:46
8/19/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagSchuth Alexander O.CAOCOFO,SecS-8633.220-30584I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact